Literature DB >> 18780779

Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation.

Mina Takahashi1, Fumio Otsuka, Tomoko Miyoshi, Hiroyuki Otani, Junko Goto, Misuzu Yamashita, Toshio Ogura, Hirofumi Makino, Hiroyoshi Doihara.   

Abstract

Estrogen is involved in the development and progression of breast cancer. Here, we investigated the effects of bone morphogenetic proteins (BMPs) on breast cancer cell proliferation caused by estrogen using human breast cancer MCF-7 cells. MCF-7 cells express estrogen receptors (ESR1 and ESR2), BMP receptors, and SMAD signaling molecules. Estradiol and membrane-impermeable estradiol stimulated MCF-7 cell proliferation. Estradiol also reduced mRNA levels of ESR1, aromatase, and steroid sulfatase. Treatment with BMPs and activin had no effects on MCF-7 cell proliferation. However, BMP2, BMP4, BMP6, BMP7, and activin suppressed estradiol-induced cell mitosis, with the effects of BMP6, BMP7, and activin being more prominent than those of BMP2 and BMP4. Activin decreased ESR1 mRNA expression, while BMP6 and BMP7 impaired steroid sulfatase expression in MCF-7 cells. Interestingly, SMAD1,5,8 activation elicited by BMP6 and BMP7, but not by BMP2 and BMP4, was preserved even under the exposure of a high concentration of estradiol. The difference of BMP responsiveness was likely due to the differential modulation of BMP receptor expression induced by estradiol. In this regard, estradiol decreased the expression levels of BMPR1A, BMPR1B, ACVR2A, and ACVR2B but did not affect ACVR1 and BMPRII, leading to the sustained effects of BMP6 and BMP7 in estrogen-treated MCF-7 cells. Estradiol rapidly activated MAPK phosphorylation including extracellular signal-regulated kinase 1/2, p38, and stress-activated protein kinase/c-Jun NH2-terminal kinase pathways and BMP6, BMP7, and activin preferentially inhibited estradiol-induced p38 phosphorylation. SB203580, a selective p38 MAPK inhibitor effectively suppressed estradiol-induced cell mitosis, suggesting that p38 MAPK plays a key role in estrogen-sensitive breast cancer cell proliferation. Thus, a novel interrelationship between estrogen and the breast cancer BMP system was uncovered, in which inhibitory effects of BMP6 and BMP7 on p38 signaling and steroid sulfatase expression were functionally involved in the suppression of estrogen-induced mitosis of breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18780779     DOI: 10.1677/JOE-08-0226

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  27 in total

1.  Overexpression of follistatin in the mouse epididymis disrupts fluid resorption and sperm transit in testicular excurrent ducts.

Authors:  Darcie D Seachrist; Emhonta Johnson; Christianne Magee; Colin M Clay; James K Graham; D N Rao Veeramachaneni; Ruth A Keri
Journal:  Biol Reprod       Date:  2012-08-23       Impact factor: 4.285

2.  Bone morphogenic protein-7 contributes to cerebral ischemic preconditioning induced-ischemic tolerance by activating p38 mitogen-activated protein kinase signaling pathway.

Authors:  Junhong Guan; Han Li; Tao Lv; Duo Chen; Ye Yuan; Shengtao Qu
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

3.  Dragon (repulsive guidance molecule b) inhibits IL-6 expression in macrophages.

Authors:  Yin Xia; Virna Cortez-Retamozo; Vera Niederkofler; Rishard Salie; Shanzhuo Chen; Tarek A Samad; Charles C Hong; Silvia Arber; Jatin M Vyas; Ralph Weissleder; Mikael J Pittet; Herbert Y Lin
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

Review 4.  Activin receptor-like kinases: a diverse family playing an important role in cancer.

Authors:  Holli A Loomans; Claudia D Andl
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

5.  Self-regulation of the head-inducing properties of the Spemann organizer.

Authors:  Masafumi Inui; Marco Montagner; Danny Ben-Zvi; Graziano Martello; Sandra Soligo; Andrea Manfrin; Mariaceleste Aragona; Elena Enzo; Luca Zacchigna; Francesca Zanconato; Luca Azzolin; Sirio Dupont; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

6.  17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1.

Authors:  Charlotte M François; Richard Wargnier; Florence Petit; Thibaut Goulvent; Ruth Rimokh; Isabelle Treilleux; Isabelle Ray-Coquard; Valeria Zazzu; Joëlle Cohen-Tannoudji; Céline J Guigon
Journal:  Carcinogenesis       Date:  2015-03-30       Impact factor: 4.944

7.  The influence of genetic ancestry and ethnicity on breast cancer survival associated with genetic variation in the TGF-β-signaling pathway: The Breast Cancer Health Disparities Study.

Authors:  Martha L Slattery; Abbie Lundgreen; Marianna C Stern; Lisa Hines; Roger K Wolff; Anna R Giuliano; Kathy B Baumgartner; Esther M John
Journal:  Cancer Causes Control       Date:  2013-12-12       Impact factor: 2.506

8.  Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals.

Authors:  J Huang; P Woods; D Normolle; J P Goff; P V Benos; C J Stehle; R A Steinman
Journal:  Breast Cancer Res Treat       Date:  2016-11-16       Impact factor: 4.872

Review 9.  Breast cancer stem cells, pathways and therapeutic perspectives 2011.

Authors:  Anjana Nigam
Journal:  Indian J Surg       Date:  2012-06-24       Impact factor: 0.656

10.  Regulation of GNRH production by estrogen and bone morphogenetic proteins in GT1-7 hypothalamic cells.

Authors:  Hiroyuki Otani; Fumio Otsuka; Masaya Takeda; Tomoyuki Mukai; Tomohiro Terasaka; Tomoko Miyoshi; Kenichi Inagaki; Jiro Suzuki; Toshio Ogura; Mark A Lawson; Hirofumi Makino
Journal:  J Endocrinol       Date:  2009-07-27       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.